Celsion Corporation Announces Closing of $7.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
08 avr. 2022 16h30 HE
|
Celsion Corporation
LAWRENCEVILLE, NJ, April 08, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced the closing of its previously announced registered direct...
Celsion Corporation Reported Cash Position of $56.9 million at December 31, 2021
01 avr. 2022 08h00 HE
|
Celsion Corporation
LAWRENCEVILLE, N.J., April 01, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage company focused on DNA-based immunotherapy and next-generation vaccines, today announced...
Celsion Corporation to Hold Year-End 2021 Financial Results and Business Update Conference Call on Thursday, March 31, 2022
24 mars 2022 09h00 HE
|
Celsion Corporation
LAWRENCEVILLE, N.J., March 24, 2022 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN), a clinical-stage development company focused on DNA-based immunotherapy and next-generation vaccines,...
CELSION CORPORATION ANNOUNCES ADJOURNMENT OF ANNUAL MEETING
04 juin 2021 10h11 HE
|
Celsion CORP
49% of Shares Voted, Quorum Not Established To Hold Annual Meeting Polls Remain Open Stockholders Holding Unvoted Proxies Are Strongly Encouraged to Vote Their Shares LAWRENCEVILLE, N.J.,...
ONCOTELIC THERAPEUTICS, INC. ANNOUNCES POSITIVE TOP LINE DATA FOR ARTI-19 CLINICAL TRIAL EVALUATING PULMOHEAL™ VERSUS COVID-19.
20 avr. 2021 12h00 HE
|
Oncotelic Therapeutics, Inc.
AGOURA HILLS, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- Oncotelic Therapeutics, Inc. ("Oncotelic" or the "Company") (OTCQB:OTLC), a leading developer of TGF-β therapeutics for oncology and...
CELSION CORPORATION ANNOUNCES $15 MILLION REGISTERED DIRECT OFFERING
31 mars 2021 08h00 HE
|
Celsion CORP
LAWRENCEVILLE, NJ, March 31, 2021 (GLOBE NEWSWIRE) -- Celsion Corporation (NASDAQ: CLSN) (“Celsion” or the “Company”), today announced it has entered into definitive agreements with institutional...
FluroTech Announces Its Safe Air Travel Product Solution
19 nov. 2020 09h50 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 19, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
FluroTech Announces Stadium and Arena Product Solution
18 nov. 2020 08h30 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 18, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
FluroTech Announces Stadium and Arena Product Solution
17 nov. 2020 08h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 17, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that (“FluroTest”) will launch its first product...
FluroTech Announces Joint Venture SARS-CoV2 Test Method Optimization
12 nov. 2020 09h00 HE
|
FluroTech Ltd.
CALGARY, Alberta, Nov. 12, 2020 (GLOBE NEWSWIRE) -- FluroTech Ltd. (TSXV: TEST) (OTCQB: FLURF), (“FluroTech” or “the Company”) is pleased to announce that has begun optimization of its SARS-CoV2...